MeSH D001804 - autologous blood transfusion
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Pfizer | Epoetin zeta | Retacrit | 2007-12-18 | $340 M | Y2023 | |
| Roche | Epoetin beta | NeoRecormon | 1997-07-16 | |||
| Stada Arzneimittel | Epoetin zeta | Silapo | 2007-12-18 |
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
100%4/4
Phase 3
67%4/6
Approved: 2Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use